Grade: Research grade

Factory Location: Hangzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe, Australasia,Asia,Middle East,Africa

Monthly Production Capacity: hundreds of grams

Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag

Delivery Lead Time: In stock or 2-3 weeks

Sample Provided: yes

Payment Terms: T/T

B7-33 is an artificially designed peptide similar to H2 relaxin, making a peptide consisting of 27 amino acids. B7-33 activates the signal transduction of relaxin peptide receptor 1 by preferentially activating protein kinase extracellular signal-regulated kinase with phosphorylated mitogen. In animal model experiments, it can be concluded that B7-33 can reduce cardiomyocyte death and endoplasmic reticulum stress, protect cardiac function, and protect mice from acute myocardial injury. At the same time, B7-33 has been shown to specifically bind the relaxin receptor RXFP1 in fibroblasts in vitro, rat and mouse in vivo fibrosis models, and preferentially activate pathways related to anti-fibrosis without side effects.